top of page
Executive Spotlights

J&J buys Shockwave for $13.1B

New Brunswick, NJ and Santa Clara, CA, April 5, 2024 (JNJ) -- Johnson & Johnson has entered into an agreement to purchase Shockwave Medical Inc. for approximately $13.1 billion, aiming to enhance its presence in cardiovascular and ramp up sales growth and margin. According to a statement released by both companies on Friday, J&J will offer $335 per share in cash for Shockwave, which is headquartered in Santa Clara, California..

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page